Systemic Juvenile Idiopathic Arthritis (SJIA)

DBCOND0075611Immune System DiseasesMusculoskeletal and Connective Tissue Diseases

Systemic Juvenile Idiopathic Arthritis (SJIA) is the indication for 4 drugs in DrugBank. It is covered by 4 curated, structured indications.

Also known as
Systemic Juvenile Idiopathic Arthritis · SJIA
Classified under
Indicated drugs

Resolves to

Vocabularies
ICD-10M08.2SNOMED CT123246003MedDRA10042061UMLSC0087031

What you can answer from here — as of October 23, 2026

4Indicated drugsWith each drug's targets and mechanism
Listed above
4Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
20Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Systemic Juvenile Idiopathic Arthritis (SJIA) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In